Top News
Latest News
REGULATORY
15 Jan 2026
FDA opens smoother lanes for CRISPR firmsPARTNERSHIPS
13 Jan 2026
CRISPR tries to crack the rare-disease problemINNOVATION
9 Jan 2026
Why Gene Editing Suddenly Feels InevitablePARTNERSHIPS
16 Dec 2025
A 2021 Gene Editing Deal Still Shapes the Future of Cancer Care
CRISPR Breakthrough Brings Gene Editing Closer to Daily Care
INNOVATION
12 Dec 2025
New trial results suggest gene editing could move from rare use to everyday medicine, pending regulators
INSIGHTS
24 Nov 2025
Lipid Cuts, Big Deals, and a New CRISPR Era
CRISPR Therapeutics’ early data, major deals, and new diagnostics fuel rapid momentum in gene editing
INNOVATION
19 Nov 2025
CRISPR GPT Sparks a Faster Era in Biotech Research
A Stanford prototype hints at faster gene design and rising interest in AI guided editing
MARKET TRENDS
13 Nov 2025
Can CRISPR Deliver a Once-and-Done Cure?
Early trial results and pharma deals spur renewed confidence in curative gene editing
PARTNERSHIPS
11 Nov 2025
RNA Alliance: CRISPR and Sirius Redefine Precision Therapy
A CRISPR–Sirius alliance aims to advance siRNA therapies for safer clot prevention
RESEARCH
7 Nov 2025
Can a Single Gene Edit Stop Heart Disease?
Lilly’s Verve deal propels research into lasting genetic fixes for cholesterol
REGULATORY
6 Nov 2025
FDA Puts Intellia’s CRISPR Trials Under the Microscope
FDA’s hold on Intellia’s MAGNITUDE trials marks a sharper focus on CRISPR safety and long-term risk tracking
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.